Select your language

ISSN 2410-7751 (Print)
ISSN 2410-776X (Online)

cover biotech acta general

Biotechnologia Acta Т. 16, No. 4, 2023
P. 22-29, Bibliography 52, Engl.
UDC:  [578.8:57.083]:606

Full text: (PDF in English)


L.P. Buchatskyi1, O.V. Zaloilo1, I.A. Zaloilo1, V. V. Nedosekov2, Yu.P. Rud1

1 Taras Schevchenko Kiev National University, Ukraine
2 Royal Veterinary College, University of London, UK

Vesiculoviruses are widely used in various fields of biotechnology. This article analyzes the results of published experimental works devoted to the development of oncolytic and recombinant vaccines against emergent viral infections based on vesiculoviruses. The use of genetic engineering methods makes it possible to strengthen their immunogenicity and oncolytic potential.

Aim. Analysis and summarization of available information devoted to the development of oncolytic and other vaccines based on vesiculoviruses.

Materials and methods. Publications were selected based on the PubMed ( and Google Scholar ( databases published in 2010–2023. They include information on development of oncolytic and other vaccines based on vesiculoviruses.

Resalts. The article describes in detail the use of vesiculoviruses as a tool for creating highly active recombinant viral vaccines. These vaccines are able to protect people from emergent viral infections in various countries and may find application in anticancer therapy.

Key words: vesiculoviruses, vaccines, oncolysis.

Buchatskyi L.P.
ORCID: 0000-0003-1350-7954

Rud Yu.P. 
ORCID: 0000-0001-6927-5377

Zaloilo O.V.
ORCID: 0000-0002-0513-1611

Zaloilo I.A.
ORCID: 0000-0001-8878-0593

© Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, 2023